Navigation Links
Midwest is cost-effective for startup biotech companies

In May 2003, I wrote a column about the cost of doing business (CODB) for biotech companies in different parts of the United States. The point of the column was that one of the advantages of doing business in the Midwest is a significant cost advantage versus setting up shop in other parts of the country (or even the world).

We know that the cost of wet lab ......

Full article >>> of the biotech industry.

I will warn you in advance that I'm not going to include all 50 cities. Instead, I'm giving you a sampling of cities.

In all fairness to the European cities listed here, part of their high cost is the increased valuation of the Euro against the U.S. dollar. The U.S. dollar is currently worth about 80 percent of one Euro. The value of the Euro has increase......

Full article >>> raise more money may outweigh the higher CODB. San Diego is probably the most cost-effective place as the CODB is about the same as Chicago but with a greater ability to raise VC funds. In the Midwest, Minneapolis is clearly king when you factor in CODB and ability to raise VC money.

When I started this column back in February 2003, I did so under the firm belief that no individual was c......

Full article >>> or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 02/21/05


Related biology technology :

1. Midwest life science stocks kept sizzling in Q2
2. Midwest life science stocks sizzle in a tepid first quarter
3. A Midwest passage to India, Part II
4. Midwest offers non-stop flight to North Carolina research park
5. A Midwest life-science odyssey comes full circle
6. Midwest hotter for healthcare investments
7. A Midwest small-cap, life-science surprise package
8. 2006: A mixed blessing for Midwest life science companies
9. Midwest gaining stature in nanotech research
10. Midwest colleges strong contenders for NIH funds
11. Japan on the rebound: Implications for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Club. The event entitled “Stem Cells and Their Regenerative Powers,” was ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., ...
Breaking Biology Technology:
(Date:5/23/2017)... robotic gym for the rehabilitation and functional motor sense evaluation of lower ... . The first 30 robots will be available from June in ... The technology was developed and patented at the IIT laboratories and has ... to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):